Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$9.53B |
| 2 |
Gilead Sciences
GILD
|
+$8.17B |
| 3 |
Microsoft
MSFT
|
+$7.02B |
| 4 |
Amgen
AMGN
|
+$6.96B |
| 5 |
Altria Group
MO
|
+$5.42B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.95% |
| 2 | Technology | 12.52% |
| 3 | Communication Services | 11.55% |
| 4 | Industrials | 10.7% |
| 5 | Consumer Staples | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
US Bancorp
USB
$101B
| $322M | 0.14% |
+8,911,079
| New | +$306M |
|
152
Berkshire Hathaway Class B
BRK.B
$1.09T
| $321M | 0.14% |
+2,865,000
| New | +$315M |
|
153
AptarGroup
ATR
$8.47B
| $318M | 0.14% |
+5,766,500
| New | +$324M |
|
154
Royal Bank of Canada
RY
$297B
| $317M | 0.13% |
+5,435,211
| New | +$325M |
|
|
DNY
155
DELISTED
DONNELLEY R R & SONS CO
DNY
| $315M | 0.13% |
+22,476,957
| New | +$315M |
|
156
Verisk Analytics
VRSK
$23.5B
| $308M | 0.13% |
+5,167,300
| New | +$309M |
|
157
Ford
F
$55.2B
| $300M | 0.13% |
+19,423,000
| New | +$278M |
|
158
Newmont
NEM
$124B
| $299M | 0.13% |
+9,968,000
| New | +$335M |
|
159
Southwest Airlines
LUV
$22B
| $295M | 0.13% |
+22,898,300
| New | +$312M |
|
160
Factset
FDS
$9.89B
| $293M | 0.12% |
+2,874,200
| New | +$276M |
|
|
LGF
161
DELISTED
Lions Gate Entertainment
LGF
| $286M | 0.12% |
+10,407,121
| New | +$273M |
|
162
Medtronic
MDT
$116B
| $286M | 0.12% |
+5,550,000
| New | +$274M |
|
163
AutoNation
AN
$6.9B
| $284M | 0.12% |
+6,535,000
| New | +$292M |
|
|
ALTR
164
DELISTED
Altera Corp
ALTR
| $280M | 0.12% |
+8,500,000
| New | +$279M |
|
|
SINA
165
DELISTED
Sina Corp
SINA
| $274M | 0.12% |
+4,914,768
| New | +$268M |
|
|
WFM
166
DELISTED
Whole Foods Market Inc
WFM
| $268M | 0.11% |
+5,214,000
| New | +$252M |
|
167
RPM International
RPM
$14.7B
| $266M | 0.11% |
+8,340,000
| New | +$268M |
|
|
UPL
168
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $263M | 0.11% |
+13,294,500
| New | +$284M |
|
169
General Mills
GIS
$20.4B
| $263M | 0.11% |
+5,420,000
| New | +$267M |
|
170
Las Vegas Sands
LVS
$29.6B
| $262M | 0.11% |
+4,950,000
| New | +$277M |
|
171
Xcel Energy
XEL
$49.1B
| $259M | 0.11% |
+9,131,000
| New | +$273M |
|
|
XLNX
172
DELISTED
Xilinx Inc
XLNX
| $256M | 0.11% |
+6,470,800
| New | +$249M |
|
|
VAL
173
DELISTED
Valspar
VAL
| $251M | 0.11% |
+3,883,285
| New | +$258M |
|
|
WW
174
DELISTED
WW International
WW
| $247M | 0.1% |
+5,364,000
| New | +$234M |
|
175
Autodesk
ADSK
$52.7B
| $245M | 0.1% |
+7,205,000
| New | +$268M |
|
Similar funds
Capital Research Global Investors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Capital Research Global Investors, which disclosed 433 positions worth $235B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Philip Morris: 102,547,012 shares worth $8.88B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q2 2013 buy was Philip Morris: 102,547,012 shares worth $8.88B.
- Capital Research Global Investors's ten largest holdings make up 25% of its $235B portfolio in Q2 2013.
- Capital Research Global Investors disclosed 433 positions in Q2 2013, its first 13F filing on record.
Based on Capital Research Global Investors's 13F filing for Q2 2013, filed 14 Aug 2013.